NCT02553707View on ClinicalTrials.gov

A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer

PHASE4CompletedINTERVENTIONAL

Enrollment

182

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Pain; Bone Neoplasms; Neoplasm Metastasis

Interventions

DRUG

Ibandronate

Participants will receive ibandronate 6 mg IV on Days 1, 2, and 3.

Trial Locations (15)

1031

Budapest

1082

Budapest

1106

Budapest

1122

Budapest

1135

Budapest

1145

Budapest

4400

Nyíregyháza

5700

Gyula

6000

Kecskemét

6720

Szeged

8000

Székesfehérvár

8200

Veszprém

8900

Zalaegerszeg

9002

Győr

9700

Szombathely

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02553707 - A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer | Biotech Hunter | Biotech Hunter